west virginia glp-1 side effect lawsuit Trulicity [2026] Exploring the Side Effects of

Data from already published studies is presented in this review

Potential side effects of Semaglutide GLP-1, such as nausea, vomiting, and diarrhea due to appetite suppression and slower gastric emptying, could be more pronounced in individuals with a lower BMI

It is your responsibility to review this disclaimer regularly for any changes

Forty percentage of the individuals on the two highest doses of survodutide had a mean weight loss of 20%

The lawsuits argue that Novo Nordisk was aware, or should have been aware, of the potential for these severe side effects but failed to provide sufficient warnings to consumers and healthcare professionals

FDA-approved GLP-1 medications have substantial clinical trial evidence for chronic weight management in appropriate patients